transpupilary thermotherapy of occult subfoveal choroidal neovascularization secondary to age related macular degeneration

Authors

m. h. dehghan department of ophthalmology and ophthalmic research center.

m. soheilian department of ophthalmology and ophthalmic research center, labbafinejad medical center, boostan 9,st., pasdaran ave., tehran, i.r. iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (shahid beheshti university of medical sciences)سازمان های دیگر: labbafinejad medical center

j. naghibozakerin department of ophthalmology and ophthalmic research center

a. papi negah eye center, tehran, i.r. iran.

abstract

abstract background: transpupillary thermotherapy is a new treatment for subfoveal choroidal neovascularization which needs further evaluation. this study was aimed to evaluate the efficacy of transpupillary thermotherapy on regression of occult subfoveal choroidal neovascularization with or without pigment epithelial detachment in patients with age-related macular degeneration. methods: in a case series study, patients with age-related macular degeneration who had occult subfoveal choroidal neovascularization less than 4 disc diameters with or without pigment epithelial detachment underwent transpupillary thermotherapy by diode laser. the patients were followed for 1-12 months. main outcome measures were visual acuity changes, flattening of pigment epithelial detachment observed clinically, or absence of leakage in angiography. the data were analyzed using t-test and chi- square. results: the study included 30 eyes of 30 patients. mean age of the patients was 67±7 years. mean follow up time was 5.3±0.5 months. visual acuity improved in 63%, remained unchanged in 20%, and worsened in 17%. mean visual acuity improved from 1.25±0.4 log mar (20/320) to 1.06±0.36 log mar (20/200), (p< 0.04). choroidal atrophy or flat scar was achieved in 73% and failure to treatment was seen in 27%, (p =0.0001). pigment epithelial detachment flattened in all cases after transpupillary thermotherapy. conclusion: transpupillary thermotherapy may be a particularly useful modality for treating occult subfoveal choroidal neovascularization associated with serous pigment epithelial detachment in selected cases of age-related macular degeneration.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Transpupilary thermotherapy of occult subfoveal choroidal neovascularization secondary to age related macular degeneration

 Abstract Background: Transpupillary thermotherapy is a new treatment for subfoveal choroidal neovascularization which needs further evaluation. This study was aimed to evaluate the efficacy of transpupillary thermotherapy on regression of occult subfoveal choroidal neovascularization with or without pigment epithelial detachment in patients with age-related macular degeneration. Methods: In a ...

full text

Transpupilary thermotherapy of occult subfoveal choroidal neovascularization secondary to age related macular degeneration

Background: Transpupillary thermotherapy is a new treatment for subfoveal choroidal neovascularization which needs further evaluation. This study was aimed to evaluate the efficacy of transpupillary thermotherapy on regression of occult subfoveal choroidal neovascularization with or without pigment epithelial detachment in patients with age-related macular degeneration. Methods: In a case serie...

full text

TRANSPUPILLARY THERMOTHERAPY (TTT): A novel approach in the treatment of occult subfoveal choroidal neovascularization in age-related macular degeneration

Dr. Ashish Vaidya Vitreo-retinal Consultant, Bombay City Eye Institute. Dr. Jigisha Shah Fellow, Bombay City Eye Institute INTRODUCTION: ARMD is a leading cause of central vision loss in patients older than 50 years of age. The majority of eyes suffer severe vision loss as a result of choroidal neovascularization, the only proven effective treatment for which is laser photocoagulation. The Macu...

full text

Bevacizumab for occult subfoveal neovascularization in age-related macular degeneration.

PURPOSE To report on the treatment of exudative age-related macular degeneration by intravitreal bevacizumab (Avastin). METHODS A 78-year-old patient experienced a progressive loss of visual acuity in her right eye due to an occult subfoveal neovascular membrane in age-related macular degeneration. She received an intravitreal injection of 1.5 mg bevacizumab. RESULTS Within 4 weeks after th...

full text

Photodynamic therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration.

BACKGROUND To evaluate the safety and efficacy of verteporfin photodynamic therapy (PDT) in patients with subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). METHODS We retrospectively reviewed the chart records and fluorescein angiography of patients with subfoveal CNV who were treated with verteporfin PDT between September 2001 and March 2003 an...

full text

Choroidal neovascularization and age-related macular degeneration.

and dysfunctional RPE are thought to be pivotal.66 CSR is a common maculopathy that can adversely affect central visual function and is 6-fold more common in males than females.67 Affected patients are typically between 30 and 50 years of age. Many putative risk factors exist for the development of CSR, the most conclusive being any form of exogenous corticosteroid use. Other risk factors inclu...

full text

My Resources

Save resource for easier access later


Journal title:
medical journal of islamic republic of iran

جلد ۲۰، شماره ۴، صفحات ۱۷۵-۱۸۰

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023